| α-SMA | α-smooth muscle actin |
| AGE | Advanced Glycation End |
| ALK | Activin-like kinase |
| APC | Adematous Polyposis Coli |
| APCs | Antigen Presenting Cells |
| BMP | Bone Morphogenic Protein |
| CAFs | Cancer-Associated Fibroblasts |
| Cav1 | Caveolin 1 |
| CDK | Cyclin-dependent kinase |
| CSL | C-promoter binding factor 1 (CBF1), suppressor of hairless (Su(H)), lin-12 and glp1 (Lag1) |
| COL1A1 | Collagen type I alpha 1 |
| CTGF | Connective Tissue Growth Factor |
| DCCT | Diabetes Control and Complications Trial |
| DDL | Deep dermal layer |
| DFF | Diabetic Foot Fibroblasts |
| DFU | Diabetic Foot Ulcer |
| DFUF | Diabetic Foot Ulcer Fibroblasts |
| Dlk1 | Delta-like non-canonical Notch ligand 1 |
| DM | Diabetes Mellitus |
| DNMT | DNA methyltransferase |
| DW | Diabetic Wound |
| ECM | Extracellular Matrix |
| EDIC | Epidemiology of Diabetes Interventions and Complications |
| EGF | Epidermal Growth Factor |
| ERK | Extracellular signal-regulated kinase |
| FAP | Fibroblast Activation Protein |
| Fbn1 | Fibrillin |
| FGF | Fibroblast Growth Factor |
| FSP1 | Fibroblast-specific protein 1 |
| FOXO1 | Forkhead box protein O1 |
| GSK | Glycogen synthase kinase |
| HGF | Hepatocyte Growth Factor |
| IFNγ | Interferon γ |
| IL | Interleukin |
| Itga8 | Alpha-8 integrin |
| ITG-β1 | Integrin-β1 |
| LEA | Lower extremity amputation |
| LPS | Lipopolysaccharides |
| LRIG1 | Leucine-rich repeats and immunoglobulin-like domains 1 |
| MAPK | Mitogen-activated protein kinase |
| MEK | Mitogen-activated extracellular signal-regulated kinase |
| MMPs | Matrix Metalloproteinases |
| MyoD | Myogenic Differentiation |
| NET | Neutrophil Extracellular Trap |
| NFF | Non-diabetic Foot Fibroblasts |
| NG2 | Neural/Glial antigen 2 |
| NLRP3 | Nod-Like Receptor Protein 3 |
| NOS | Nitric oxide synthase |
| PDGF | Platelet-Derived Growth Factor |
| PDGFR | Platelet Derived Growth Factor Receptor |
| Pdpn | Podoplanin |
| PGE2 | Prostaglandin E2 |
| ROS | Reactive Oxygen Species |
| SDL | Deep dermal layer |
| T2DM | Type 2 Diabetes Mellitus |
| TCF/LEF | T-cell factor/lymphoid enhancer factor |
| TGF-β | Transforming Growth Factor-β |
| TIMPs | Tissue Inhibitors of Metalloproteinases |
| TLR | Toll-Like Receptor |
| TNF-α | Tumor Necrosis Factor- α |
| VEGF | Vascular Endothelial Growth Factor |
| Wnt | Wingless-related integration site |